IGC Pharma, Inc. Common Stock (NY:IGC)

0.2470 -0.0030 (-1.20%)

Delayed Quote Updated: 1:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 25, 2024

Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!

Via InvestorPlace

IGC Stock Earnings: IGC Pharma Meets EPS, Beats Revenue for Q4 2024 ↗

June 24, 2024

IGC stock results show that IGC Pharma met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024.

Via InvestorPlace

IGC Reports Financial Results for Fiscal Year Ended March 31, 2024

June 24, 2024

From IGC Pharma, Inc.

Via Business Wire

BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Execs Slated to Present at Upcoming Ascendiant Capital Markets Event

June 18, 2024

Via Investor Brand Network

Topics Artificial Intelligence

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

June 18, 2024

From IGC Pharma, Inc.

Via Business Wire

Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected ↗

June 13, 2024

Discover how Anson Funds settled with the SEC for $2.25M over an undisclosed collaboration with short seller impacting cannabis stocks

Via Benzinga

Topics Cannabis Regulatory Compliance

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 11, 2024

Via Benzinga

BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Publication of Key Study in European Journal

June 10, 2024

Via Investor Brand Network

Topics Artificial Intelligence

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

June 10, 2024

From IGC Pharma, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 31, 2024

Via Benzinga

BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Initiates Patient Enrollment in Phase 2 Trial Investigating IGC-AD1

May 28, 2024

Via Investor Brand Network

Topics Artificial Intelligence

IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1

May 28, 2024

From IGC Pharma Inc.

Via Business Wire

BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Management Hosting Meetings at Upcoming BIO International Convention 2024

May 22, 2024

Via Investor Brand Network

Topics Artificial Intelligence

IGC Pharma to Attend BIO International Convention 2024

May 21, 2024

From IGC Pharma Inc.

Via Business Wire

6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings

May 09, 2024

6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings

Via News Direct

6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings

May 09, 2024

By Faith Ashmore, Benzinga

Via TheNewswire.com

Topics Cannabis

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 01, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 01, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 29, 2024

Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 16, 2024

Via Benzinga

BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Shares Positive Interim Results on IGC-AD1 for Agitation in Alzheimer’s

April 16, 2024

Via Investor Brand Network

Topics Artificial Intelligence Cannabis

IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation ↗

April 16, 2024

IGC Pharma shares encouraging interim data from Phase 2 trial of IGC-AD1 for Alzheimer's agitation. Results suggest significant reduction in agitation with minimal side effects compared to placebo.

Via Benzinga

IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two

April 16, 2024

From IGC Pharma, Inc.

Via Business Wire

Who's Who In Cannabis: Latest Executive Changes You Should Know About ↗

April 15, 2024

Via Benzinga

BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Adds AI Expert to Support Development of Phase 2 Clinical Trial

April 09, 2024

Via Investor Brand Network

Topics Artificial Intelligence

IGC Pharma Adds Advisor in Artificial Intelligence

April 09, 2024

From IGC Pharma, Inc.

Via Business Wire

IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research

April 03, 2024

--News Direct--

Via News Direct

IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research ↗

April 02, 2024

Via Benzinga

InvestorNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Enters into $3M SPA with Leading Asset Management Company

March 27, 2024

Via Investor Brand Network

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.